429 related articles for article (PubMed ID: 20049846)
41. HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
Chen CH; Chang WH; Su KY; Ku WH; Chang GC; Hong QS; Hsiao YJ; Chen HC; Chen HY; Wu R; Yang PC; Chen JJ; Yu SL
Oncogene; 2016 Oct; 35(43):5674-5685. PubMed ID: 27065329
[TBL] [Abstract][Full Text] [Related]
42. SRC kinase inhibitors: an update on patented compounds.
Schenone S; Brullo C; Musumeci F; Radi M; Castagnolo D
Curr Med Chem; 2011; 18(33):5061-78. PubMed ID: 22050754
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, Biological, and Computational Evaluation of Novel 1,3,5-Substituted Indolin-2-one Derivatives as Inhibitors of Src Tyrosine Kinase.
Kilic-Kurt Z; Bakar F; Ölgen S
Arch Pharm (Weinheim); 2015 Oct; 348(10):715-29. PubMed ID: 26260414
[TBL] [Abstract][Full Text] [Related]
44. Synthetic SRC-kinase domain inhibitors and their structural requirements.
Schenone S; Manetti F; Botta M
Anticancer Agents Med Chem; 2007 Nov; 7(6):660-80. PubMed ID: 18045061
[TBL] [Abstract][Full Text] [Related]
45. Targeting Src in breast cancer.
Finn RS
Ann Oncol; 2008 Aug; 19(8):1379-1386. PubMed ID: 18487549
[TBL] [Abstract][Full Text] [Related]
46. Src redox regulation: there is more than meets the eye.
Chiarugi P
Mol Cells; 2008 Oct; 26(4):329-37. PubMed ID: 18772619
[TBL] [Abstract][Full Text] [Related]
47. Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.
Teli G; Pal R; Maji L; Sengupta S; Raghavendra NM; Matada GSP
Chem Biodivers; 2023 Sep; 20(9):e202300515. PubMed ID: 37563848
[TBL] [Abstract][Full Text] [Related]
48. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.
Kim MP; Park SI; Kopetz S; Gallick GE
Cell Tissue Res; 2009 Jan; 335(1):249-59. PubMed ID: 18815812
[TBL] [Abstract][Full Text] [Related]
49. The role of Src in solid tumors.
Wheeler DL; Iida M; Dunn EF
Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
[TBL] [Abstract][Full Text] [Related]
50. Exquisitely specific bisubstrate inhibitors of c-Src kinase.
Brandvold KR; Santos SM; Breen ME; Lachacz EJ; Steffey ME; Soellner MB
ACS Chem Biol; 2015 Jun; 10(6):1387-91. PubMed ID: 25793938
[TBL] [Abstract][Full Text] [Related]
51. Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity.
Chaudhary F; Lucito R; Tonks NK
Biochem J; 2015 Jan; 465(1):89-101. PubMed ID: 25287652
[TBL] [Abstract][Full Text] [Related]
52. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
Johnson FM; Gallick GE
Anticancer Agents Med Chem; 2007 Nov; 7(6):651-9. PubMed ID: 18045060
[TBL] [Abstract][Full Text] [Related]
53. Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition.
Ortiz MA; Mikhailova T; Li X; Porter BA; Bah A; Kotula L
Cell Commun Signal; 2021 Jun; 19(1):67. PubMed ID: 34193161
[TBL] [Abstract][Full Text] [Related]
54. SRC inhibitors as potential therapeutic agents for human cancers.
Trevino JG; Summy JM; Gallick GE
Mini Rev Med Chem; 2006 Jun; 6(6):681-7. PubMed ID: 16787379
[TBL] [Abstract][Full Text] [Related]
55. The Src signaling pathway: a potential target in melanoma and other malignancies.
Homsi J; Cubitt C; Daud A
Expert Opin Ther Targets; 2007 Jan; 11(1):91-100. PubMed ID: 17150037
[TBL] [Abstract][Full Text] [Related]
56. Novel regulation and function of Src tyrosine kinase.
Ma YC; Huang XY
Cell Mol Life Sci; 2002 Mar; 59(3):456-62. PubMed ID: 11964124
[TBL] [Abstract][Full Text] [Related]
57. Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.
Patel A; Sabbineni H; Clarke A; Somanath PR
Life Sci; 2016 Jul; 157():52-61. PubMed ID: 27245276
[TBL] [Abstract][Full Text] [Related]
58. Src in cancer: deregulation and consequences for cell behaviour.
Frame MC
Biochim Biophys Acta; 2002 Jun; 1602(2):114-30. PubMed ID: 12020799
[TBL] [Abstract][Full Text] [Related]
59. SRC inhibitors and angiogenesis.
Schenone S; Manetti F; Botta M
Curr Pharm Des; 2007; 13(21):2118-28. PubMed ID: 17627544
[TBL] [Abstract][Full Text] [Related]
60. Src kinase and pancreatic cancer.
Hilbig A
Recent Results Cancer Res; 2008; 177():179-85. PubMed ID: 18084959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
